2017 Vol.35, N°4 - Table of contents
July-August 2017
One year in review
CER10631
2017,35,4
Pg. 0551-0561
Free to view
One year in review 2017: systemic lupus erythematosus
G.M.C. La Paglia, M.C. Leone, G. Lepri, R. Vagelli, E. Valentini, A. Alunno, C. Tani
G.M.C. La Paglia, M.C. Leone, G. Lepri, R. Vagelli, E. Valentini, A. Alunno, C. Tani
Full Papers
CER9851
2017,35,4
Pg. 0562-0570
Free to view
Abatacept therapy reduces CD28+CXCR5+ follicular helper-like T cells in patients with rheumatoid arthritis
S. Fukuyo, S. Nakayamada, S. Iwata, S. Kubo, K. Saito, Y. Tanaka
S. Fukuyo, S. Nakayamada, S. Iwata, S. Kubo, K. Saito, Y. Tanaka
CER9931
2017,35,4
Pg. 0571-0578
Free to view
Fatigue contributes to work productivity impairment in patients with axial spondyloarthritis: a cross-sectional UK study
S. Espahbodi, P. Bassett, C. Cavill, M. Freeth, J. Hole, R. Sengupta
S. Espahbodi, P. Bassett, C. Cavill, M. Freeth, J. Hole, R. Sengupta
CER10025
2017,35,4
Pg. 0579-0585
Free to view
Biologic treatment for rheumatic disease: real-world big data analysis from the Greek country-wide prescription database
P.P. Sfikakis, V.-K. Bournia, P. Sidiropoulos, D.T. Boumpas, A.A. Drosos, G.D. Kitas, G. Konstantonis, S.N. Liossis, M.N. Manoussakis, L. Sakkas, M. Tektonidou, A.G. Tzioufas, P.G. Vlachoyiannopoulos, C. Kani, P. Paterakis, P. Litsa, D. Vassilopoulos
P.P. Sfikakis, V.-K. Bournia, P. Sidiropoulos, D.T. Boumpas, A.A. Drosos, G.D. Kitas, G. Konstantonis, S.N. Liossis, M.N. Manoussakis, L. Sakkas, M. Tektonidou, A.G. Tzioufas, P.G. Vlachoyiannopoulos, C. Kani, P. Paterakis, P. Litsa, D. Vassilopoulos
CER9969
2017,35,4
Pg. 0586-0592
Free to view
Detecting novel micro RNAs in rheumatoid arthritis with gene-based association testing
A. Lenert, D.W. Fardo
A. Lenert, D.W. Fardo
CER10019
2017,35,4
Pg. 0593-0597
Free to view
Direct suppression of autoaggressive CD8+ T cells with CD80/86 blockade in CD8+ T cell-mediated polymyositis models of mice
H. Hasegawa, K. Kawahata, F. Mizoguchi, N. Okiyama, N. Miyasaka, H. Kohsaka
H. Hasegawa, K. Kawahata, F. Mizoguchi, N. Okiyama, N. Miyasaka, H. Kohsaka
CER9757
2017,35,4
Pg. 0598-0606
Free to view
What is the clinical significance of anti-Sm antibodies in systemic lupus erythematosus? A comparison with anti-dsDNA antibodies and C3
A. Flechsig, T. Rose, F. Barkhudarova, R. Strauss, J. Klotsche, C. Dähnrich, W. Schlumberger, P. Enghard, G.-R. Burmester, F. Hiepe, R. Biesen
A. Flechsig, T. Rose, F. Barkhudarova, R. Strauss, J. Klotsche, C. Dähnrich, W. Schlumberger, P. Enghard, G.-R. Burmester, F. Hiepe, R. Biesen
CER9839
2017,35,4
Pg. 0607-0613
Free to view
Development and validation of rheumatoid arthritis magnetic resonance imaging inflammation thresholds associated with lack of damage progression
J.F. Baker, M. Østergaard, P. Emery, D.G. Baker, P.G. Conaghan
J.F. Baker, M. Østergaard, P. Emery, D.G. Baker, P.G. Conaghan
CER10016
2017,35,4
Pg. 0614-0622
Free to view
Analysis of non-melanoma skin cancer across the tofacitinib rheumatoid arthritis clinical programme
J.R. Curtis, E.B. Lee, G. Martin, X. Mariette, K.K. Terry, Y. Chen, J. Geier, J. Andrews, M. Kaur, H. Fan, C.I. Nduaka
J.R. Curtis, E.B. Lee, G. Martin, X. Mariette, K.K. Terry, Y. Chen, J. Geier, J. Andrews, M. Kaur, H. Fan, C.I. Nduaka
CER9655
2017,35,4
Pg. 0623-0629
Free to view
What could we learn from the sub-analysis of a single nation cohort in a worldwide study? Lessons from the results observed in the Italian cohort of the GO-MORE trial
R. Giacomelli, P. Ruscitti, S. Bombardieri, G. Cuomo, S. De Vita, M. Galeazzi, M. Mecchia
on behalf of the Italian GO-MORE Investigators
R. Giacomelli, P. Ruscitti, S. Bombardieri, G. Cuomo, S. De Vita, M. Galeazzi, M. Mecchia
on behalf of the Italian GO-MORE Investigators
CER9960
2017,35,4
Pg. 0630-0637
Free to view
Differential expressions of NOD-like receptors and their associations with inflammatory responses in rheumatoid arthritis
H.W. Kim, Y.-J. Kwon, B.W. Park, J.J. Song, Y.-B. Park, M.C. Park
H.W. Kim, Y.-J. Kwon, B.W. Park, J.J. Song, Y.-B. Park, M.C. Park
CER9710
2017,35,4
Pg. 0638-0646
Free to view
Glucocorticoid-sparing effect of first-year anti-TNFα treatment in rheumatoid arthritis (CORPUS Cohort)
C. Duquenne, D. Wendling, J. Sibilia, C. Job-Deslandre, L. Guillevin, J. Benichou, R.M. Flipo, F. Guillemin, A. Saraux
C. Duquenne, D. Wendling, J. Sibilia, C. Job-Deslandre, L. Guillevin, J. Benichou, R.M. Flipo, F. Guillemin, A. Saraux
CER10004
2017,35,4
Pg. 0647-0652
Free to view
Diagnostic accuracy of musculoskeletal ultrasound and conventional radiography in the assessment of the wrist triangular fibrocartilage complex in patients with definite diagnosis of calcium pyrophosphate dihydrate deposition disease
A. Di Matteo, E. Filippucci, F. Salaffi, M. Carotti, D. Carboni, E. Di Donato, W. Grassi
A. Di Matteo, E. Filippucci, F. Salaffi, M. Carotti, D. Carboni, E. Di Donato, W. Grassi
CER9982
2017,35,4
Pg. 0653-0659
Free to view
Type I and III collagen turnover is increased in axial spondyloarthritis and psoriatic arthritis. Associations with disease activity and diagnostic capacity
N.S. Gudmann, A.S. Siebuhr, A.F. Christensen, L. Ejstrup, G.L. Sørensen, A.G. Loft, M.A. Karsdal, A.-C. Bay-Jensen, H.L. Munk, P. Junker
N.S. Gudmann, A.S. Siebuhr, A.F. Christensen, L. Ejstrup, G.L. Sørensen, A.G. Loft, M.A. Karsdal, A.-C. Bay-Jensen, H.L. Munk, P. Junker
CER9815
2017,35,4
Pg. 0660-0665
Free to view
Comparison of efficacy of first- versus second-line adalimumab in patients with rheumatoid arthritis: experience of the Italian biologics registries
V. Codullo, F. Iannone, L. Sinigaglia, E.G. Favalli, P. Sarzi-Puttini, F. Atzeni, G. Ferraccioli, E. Gremese, A. Carletto, A. Giollo, M. Govoni, F. Bergossi, M. Galeazzi, L. Cantarini, F. Salaffi, M. Di Carlo, C. Bazzani, R. Pellerito, M. Sebastiani, R. Ramonda, G. Lapadula, R. Caporali
V. Codullo, F. Iannone, L. Sinigaglia, E.G. Favalli, P. Sarzi-Puttini, F. Atzeni, G. Ferraccioli, E. Gremese, A. Carletto, A. Giollo, M. Govoni, F. Bergossi, M. Galeazzi, L. Cantarini, F. Salaffi, M. Di Carlo, C. Bazzani, R. Pellerito, M. Sebastiani, R. Ramonda, G. Lapadula, R. Caporali
CER9899
2017,35,4
Pg. 0666-0670
Free to view
Successful extension of tocilizumab infusion intervals from 4 weeks to 6 or 5 weeks in 90[%] of RA patients with good response to 4-week intervals
O. Saiki, H. Uda
O. Saiki, H. Uda
Brief Papers
CER9877
2017,35,4
Pg. 0671-0673
Free to view
Pneumocystis jiroveci pneumonia in rheumatic disease: a 20-year single-centre experience
C.A. Mecoli, D. Saylor, A.C. Gelber, L. Christopher-Stine
C.A. Mecoli, D. Saylor, A.C. Gelber, L. Christopher-Stine
CER9576
2017,35,4
Pg. 0674-0677
Free to view
Jaccoud’s arthropathy in systemic lupus erythematosus: clinical, laboratory and ultrasonographic features
F. Ceccarelli, L. Massaro, C. Perricone, M. Pendolino, E. Cipriano, S. Truglia, F. Miranda, F.R. Spinelli, C. Alessandri, G. Valesini, F. Conti
F. Ceccarelli, L. Massaro, C. Perricone, M. Pendolino, E. Cipriano, S. Truglia, F. Miranda, F.R. Spinelli, C. Alessandri, G. Valesini, F. Conti
Case Reports
CER10069
2017,35,4
Pg. 0678-0680
Free to view
Diagnosis of catastrophic anti-phospholipid syndrome in a patient tested negative for conventional tests
F. Conti, R. Priori, C. Alessandri, R. Misasi, A. Capozzi, M. Pendolino, S. Truglia, S. Frisenda, M. Sorice, G. Valesini
F. Conti, R. Priori, C. Alessandri, R. Misasi, A. Capozzi, M. Pendolino, S. Truglia, S. Frisenda, M. Sorice, G. Valesini
Review
CER9749
2017,35,4
Pg. 0681-0688
Free to view
Treatment modifying factors of biologics for psoriatic arthritis: a systematic review and Bayesian meta-regression
E. Druyts, J.B. Palmer, C. Balijepalli, K. Chan, M.S. Fazeli, V. Herrera, J.P. Jansen, J.J. Park, S. Kanters, A. Reimold
E. Druyts, J.B. Palmer, C. Balijepalli, K. Chan, M.S. Fazeli, V. Herrera, J.P. Jansen, J.J. Park, S. Kanters, A. Reimold
CER9883
2017,35,4
Pg. 0689-0699
Free to view
A comparison of discontinuation rates of tofacitinib and biologic disease-modifying anti-rheumatic drugs in rheumatoid arthritis: a systematic review and Bayesian network meta-analysis
S.-K. Park, M.-Y. Lee, E.-J. Jang, H.-L. Kim, D.-M. Ha, E.-K. Lee
S.-K. Park, M.-Y. Lee, E.-J. Jang, H.-L. Kim, D.-M. Ha, E.-K. Lee
CER9861
2017,35,4
Pg. 0700-0710
Free to view
A meta-analysis of avascular necrosis in systemic lupus erythematosus: prevalence and risk factors
T. Nevskaya, M.P. Gamble, J.E. Pope
T. Nevskaya, M.P. Gamble, J.E. Pope
Paediatric Rheumatology
CER9977
2017,35,4
Pg. 0711-0715
Free to view
Immunogenicity and safety of the inactivated hepatitis A vaccine in children with juvenile idiopathic arthritis on methotrexate treatment: a matched case-control study
D.N. Maritsi, S.E. Coffin, I. Argyri, G. Vartzelis, N. Spyridis, M.N. Tsolia
D.N. Maritsi, S.E. Coffin, I. Argyri, G. Vartzelis, N. Spyridis, M.N. Tsolia
Letters to the Editor
CER10353
2017,35,4
Pg. 0716
Free to view
Sarcoidosis and tocilizumab: is there a link?
L. Bustamente, M. Buscot, C.-H. Marquette, C. Roux
L. Bustamente, M. Buscot, C.-H. Marquette, C. Roux
CER10369
2017,35,4
Pg. 0717
Free to view
One biopsy, two diagnoses: statin-induced autoimmune myopathy in combination with extranodal marginal zone lymphoma
S. Michiels, D. Dierickx, V. Taelman, T. Tousseyn, J. Lenaerts, E. De Langhe
S. Michiels, D. Dierickx, V. Taelman, T. Tousseyn, J. Lenaerts, E. De Langhe
CER10312
2017,35,4
Pg. 0718
Free to view
RAPID3 correlates with ESSPRI and other patient-reported outcomes in patients with primary Sjögren's syndrome
M. Pertovaara, M. Korpela
M. Pertovaara, M. Korpela
CER10038
2017,35,4
Pg. 0719-0720
Free to view
Type I interferon signature may influence the effect of belimumab on immunoglobulin levels, including rheumatoid factor in Sjögren’s syndrome
L. Quartuccio, C.P. Mavragani, A. Nezos, S. Gandolfo, A.G. Tzioufas, S. De Vita
L. Quartuccio, C.P. Mavragani, A. Nezos, S. Gandolfo, A.G. Tzioufas, S. De Vita
Erratum Corrige
CER10685
2017,35,4
Pg. 0720
Free to view
A cautionary tale: dealing with missing data in clinical trials for rheumatic diseases
No Author
No Author